Baxter Healthcare Corporation

Baxter Healthcare Corporation
Share

Baxter is the world’s leading manufacturer of commercially prepared IV solutions as well as frozen and ready-to-use premixed drugs in flexible IV containers. Baxter’s portfolio of IV solutions and premixed drugs is the broadest in the industry. IV infusion pumps and administration sets control the delivery of IV fluids and drugs to patients.

New ASPEN Parenteral Nutrition Appropriate Use Recommendations Designed to Help Improve Patient Outcomes Malnourished Patients in U.S. Hospitals are 54 Percent More Likely to be Readmitted; Have Five Times Higher Risk of Death New Educational Resources Available to Help Promote Clinical Benefits, Minimize Risks of Parenteral Nutrition Therapy...

DEERFIELD, Ill., August 21, 2017 — Baxter International Inc. (NYSE: BAX) will present at the Morgan Stanley 15th Annual Global Healthcare Conference on Monday, September 11, 2017 in New York. José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 1:40 p.m. Eastern Time. The live webcast of Baxter’s...

DEERFIELD, Ill., August 15, 2017 — Baxter International Inc. (NYSE: BAX) will present at the Goldman Sachs 14th Annual European Medtech and Healthcare Services Conference on Wednesday, September 6, 2017, in London. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 7:45 a.m. Central Time. The live webcast of Baxter’s...

Increases Patient Access to Medicines Provides Platform for Accelerated Growth Expected to be Modestly Accretive to Adjusted Earnings for 2017

DEERFIELD, Ill., July 27, 2017 – Baxter International Inc. (NYSE: BAX), a global medical products company, today announced the completion of the acquisition of Claris Injectables Limited, a global generic...

DEERFIELD, Ill., July 18, 2017 – Baxter International Inc. (NYSE:BAX) announced today that its Board of Directors has declared a quarterly dividend of $0.16 per share of common stock. The dividend is payable on October 2, 2017, to stockholders of record as of September 1, 2017. The indicated annual dividend rate is $0.64 per share. Baxter provides...

DoseEdge Pharmacy Workflow Manager’s integration with Epic aims to improve pharmacy safety and efficiency* New integration helps hospitals comply with regulatory and insurance requirements DEERFIELD, Ill. June 26, 2017 – Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication preparation and delivery, announced a...

Collaboration builds upon Baxter’s pending acquisition of Claris and its ScinoPharm collaboration and advances Baxter’s strategy of becoming a leader in generic injectables DEERFIELD, Ill., June 14, 2017 – Baxter International Inc. (NYSE: BAX), a global medical products company, today announced an agreement with Dorizoe Lifesciences Limited...

Only available premixed clindamycin injection in a saline presentation Provides additional access to commonly prescribed antibiotic in three standard doses Premixed presentation can help enhance patient safety and pharmacy efficiency DEERFIELD, Ill., June 7, 2017 – Baxter International Inc. (NYSE: BAX), a global leader in sterile medication...

Physicians using SHARESOURCE remote patient management – a telehealth platform – have more accurate and timely visibility to their patients’ home therapy adherence Remote patient management allows for earlier intervention in response to PD patient clinical issues
Nurses managing patients via remote patient management reported a 35 percent...

Five-year agreement brings together clinical and development expertise of two long-time healthcare leaders First project will focus on unmet needs in kidney disease treatment DEERFIELD, Ill. and JACKSONVILLE, Fla., MAY 31, 2017 – Baxter International Inc. (NYSE:BAX), a global medical products company, and Mayo Clinic today announced a new research...